The Joint Corp.
NASDAQ:JYNTMedical - Care Facilities
+$0.17 today
- Market cap
- $91.03M
- Beta
- 1.10
- P/E (TTM)
- 40.7
- EPS (TTM)
- $0.23
Volume 0.05M
Average 0.07M
JYNT Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
The Joint Corp.NASDAQ: JYNT
Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026
Depreciation & amortization growth accelerates
Q1 FY2026 depreciation & amortization of $396.69K rose 2.2% year over year, ahead of the -54.0% change in trailing-twelve-month depreciation & amortization. Sequentially, it fell 10.4% from the prior quarter. Over 3 fiscal years it compounded at -36.4% a year.
Context
- Depreciation & amortization amounted to 3.1% of revenue in FY2025, down 5.9 pp from a year earlier.
- Depreciation & amortization increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +2.2% holds above the trailing-twelve-month pace of -54.0%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the cash flow
- Latest · FY2025
- 1.71M USD
- Year-over-year change
- -63.7%
- 4-year CAGR
- -18.7%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.71M | -63.7% |
| FY2024 | 2024-12-31 | 4.72M | -45.0% |
| FY2023 | 2023-12-31 | 8.58M | +29.1% |
| FY2022 | 2022-12-31 | 6.65M | +69.5% |
| FY2021 | 2021-12-31 | 3.92M | — |
Depreciation & Amortization vs competitors
How JYNT compares with its peers on the latest reported figures
- JYNT's LTM Mar 2026 depreciation & amortization of $1.71M is the 6th largest of the 11 companies compared; the peer median is $2.01M.
- Its year-over-year change of -54.0% is the 9th highest of 11, against a peer median of +1.1%.
- Depreciation & amortization amounts to 3.0% of revenue for JYNT, versus a peer median of 5.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $429.44M | +48315.3% | -23.3% | 8364.7% | |
| LTM Mar 2026 | $14.55M | -5.9% | +14.0% | 4.8% | |
| LTM Mar 2026 | $3.79M | +3.0% | +18.6% | 2.0% | |
| LTM Mar 2026 | $3.65M | -76.2% | +2.8% | 2.9% | |
| LTM Mar 2026 | $3.11M | -8.6% | +4.7% | 9.0% | |
| LTM Mar 2026 | $1.71M | -54.0% | -36.4% | 3.0% | |
| LTM Mar 2026 | $917K | +9.7% | +7.5% | 1608.8% | |
| LTM Mar 2026 | $719K | +24.0% | -9.7% | 1.3% | |
| LTM Mar 2026 | $251K | -0.8% | -1.0% | — | |
| LTM Mar 2026 | $47.85K | +47.9% | +108.0% | — | |
| LTM Mar 2026 | $23.95K | -96.6% | -41.3% | 6.0% | |
| Peer median (excluding JYNT) | $2.01M | +1.1% | +3.8% | 5.4% | |
Competitors are the stored peer set for JYNT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 7.57M | 626.71K | (9.75M) | (8.53M) | 2.91M |
| Depreciation & Amortization | 3.92M | 6.65M | 8.58M | 4.72M | 1.71M |
| Deferred Income Tax | (1.78M) | (441.35K) | 10.9M | (55.56K) | 93.07K |
| Stock-Based Compensation | 1.06M | 1.27M | 1.74M | 1.68M | 1.3M |
| Change in Working Capital | 3.09M | (238.06K) | 798.62K | 1.1M | (9.56M) |
| Accounts Receivables | (1.64M) | (154.67K) | 192.35K | (1.65M) | 1.53M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | (14.37K) | 818.27K | (1.38M) | 68.26K | (391.13K) |
| Other Working Capital | 4.74M | (901.65K) | 1.99M | 2.68M | (10.7M) |
| Other Non-Cash Items | (7.77K) | 341.68K | 2.41M | 10.5M | 5.39M |
| Operating Cash Flow | 13.84M | 8.21M | 14.68M | 9.42M | 1.84M |
| Capital Expenditures | (6.99M) | (5.9M) | (5M) | (1.19M) | (1.5M) |
| Acquisitions (Net) | (5.77M) | (12.11M) | (1.19M) | 554.1K | 7.78M |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 105.2K | 0 | 0 | 0 |
| Investing Cash Flow | (12.75M) | (17.9M) | (6.19M) | (631.55K) | 6.27M |
| Debt Repayment | (2.81M) | (49.86K) | (24.43K) | (2.03M) | (4.35K) |
| Common Stock Issued | 0 | 0 | 202.39K | 33.71K | 1.52M |
| Common Stock Repurchased | 0 | (5.8K) | (3.83K) | (9.58K) | (11.32M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 811.59K | 384.27K | 0 | 0 | 0 |
| Financing Cash Flow | (2M) | 328.61K | 174.12K | (2M) | (9.81M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (907.29K) | (9.36M) | 8.66M | 6.78M | (1.69M) |
| Free Cash Flow | 6.85M | 2.31M | 9.68M | 8.23M | 334.72K |
The Joint Corp.
NASDAQ:JYNT
Intrinsic Alpha fair value
Locked
Current Price
$6.65
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.